Zoetis Inc. (ZTS)
| Market Cap | 77.13B |
| Revenue (ttm) | 8.01B |
| Net Income (ttm) | 2.07B |
| Shares Out | 466.07M |
| EPS (ttm) | 4.38 |
| PE Ratio | 37.78 |
| Forward PE | 30.12 |
| Dividend | $1.30 (0.79%) |
| Ex-Dividend Date | Jan 19, 2023 |
| Volume | 2,621,319 |
| Open | 164.50 |
| Previous Close | 164.70 |
| Day's Range | 162.62 - 165.71 |
| 52-Week Range | 124.15 - 205.31 |
| Beta | 0.72 |
| Analysts | Buy |
| Price Target | 212.87 (+28.63%) |
| Earnings Date | Feb 14, 2023 |
About ZTS
Zoetis Inc. discovers, develops, manufactures, and commercializes animal health medicines, vaccines, and diagnostic products in the United States and internationally. It commercializes products primarily across species, including livestock, such as cattle, swine, poultry, fish, and sheep; and companion animals comprising dogs, cats, and horses. The company also offers vaccines, which are biological preparations to prevent diseases of the respiratory, gastrointestinal, and reproductive tracts or induce a specific immune response; anti-infectives... [Read more]
Full Company ProfileFinancial Performance
In 2021, Zoetis's revenue was $7.78 billion, an increase of 16.49% compared to the previous year's $6.68 billion. Earnings were $2.04 billion, an increase of 24.36%.
Financial StatementsAnalyst Forecast
According to 20 analysts, the average rating for ZTS stock is "Buy." The 12-month stock price forecast is $212.87, which is an increase of 28.63% from the latest price.
News
UTHR vs. ZTS: Which Stock Is the Better Value Option?
UTHR vs. ZTS: Which Stock Is the Better Value Option?
Final Trades: Abbott Labs, SL Green, Zoetis & more
The "Halftime Report" traders give their top picks to watch for the second half.
COLL vs. ZTS: Which Stock Is the Better Value Option?
COLL vs. ZTS: Which Stock Is the Better Value Option?
Zoetis CEO Kristin Peck on veterinary workforce challenges and recession resilience of pet industry
Kristin Peck, CEO of Zoetis, joins 'The Exchange' to discuss the pandemic pet boom, demographic shifts among pet owners, and the labor capacity issues associated with veterinary services.
Tesla is not alone: 18 (and a half) other big stocks are headed for their worst year on record
In the worst year for stocks since the Great Recession, several big names are headed for their worst year on record with just one trading day left in 2022.
ASRT vs. ZTS: Which Stock Is the Better Value Option?
ASRT vs. ZTS: Which Stock Is the Better Value Option?
Zoetis CEO on egg price increases
Cramer spoke with Zoetis CEO Kristin Peck on Thursday.
Zoetis to Host Webcast and Conference Call on Fourth Quarter and Full Year 2022 Financial Results
PARSIPPANY, N.J.--(BUSINESS WIRE)--Zoetis Inc. (NYSE:ZTS) will host a webcast and conference call at 8:30 a.m. (ET) on Tuesday, Feb. 14, 2023. Chief Executive Officer Kristin Peck and Executive Vice...
Zoetis to Participate in the 41st Annual J.P. Morgan Healthcare Conference
PARSIPPANY, N.J.--(BUSINESS WIRE)--Zoetis Inc. (NYSE:ZTS) will participate in the 41st Annual J.P. Morgan Healthcare Conference on Monday, January 9, 2023. Kristin Peck, Chief Executive Officer, wil...
JPMorgan's bullish call on biopharma
The "Halftime Report" traders debate the biggest analyst calls of the day.
ASRT or ZTS: Which Is the Better Value Stock Right Now?
ASRT vs. ZTS: Which Stock Is the Better Value Option?
Zoetis Declares First Quarter 2023 Dividend; Board Approves 15% Payment Increase
PARSIPPANY, N.J.--(BUSINESS WIRE)--The Board of Directors of Zoetis Inc. (NYSE:ZTS) has declared a dividend of $0.375 per share for the first quarter of 2023, an increase of 15% from the quarterly d...
Zoetis to Participate in the Piper Sandler 34th Annual Healthcare Conference
PARSIPPANY, N.J.--(BUSINESS WIRE)--Zoetis Inc. (NYSE:ZTS) will participate in the Piper Sandler 34th Annual Healthcare Conference on Wednesday, November 30, 2022. Glenn David, Executive Vice Preside...
Zoetis Announces Pricing of $1.35 Billion of Senior Notes
PARSIPPANY, N.J.
ASRT vs. ZTS: Which Stock Should Value Investors Buy Now?
ASRT vs. ZTS: Which Stock Is the Better Value Option?
Demand for animal medicine remains fundamentally strong, says Zoetis CEO Kristin Peck
Zoetis CEO Kristin Peck joins 'Closing Bell' to discuss Zoetis stocks dropping after a worse than expected earnings report, the supply constraints that has been adding pressure to key growth drivers, ...
Zoetis' (ZTS) Lags Q3 Earnings Estimates, Lowers 2022 Guidance
Zoetis' (ZTS) earnings miss estimates in third-quarter 2022. Revenues, though up, also miss estimates due to the supply constraints in the international market.
Zoetis (ZTS) Q3 Earnings and Revenues Miss Estimates
Zoetis (ZTS) delivered earnings and revenue surprises of -2.42% and 3.63%, respectively, for the quarter ended September 2022. Do the numbers hold clues to what lies ahead for the stock?
Why Zoetis (ZTS) Might Surprise This Earnings Season
Zoetis (ZTS) is seeing favorable earnings estimate revision activity and has a positive Zacks Earnings ESP heading into earnings season.
Zoetis (ZTS) to Report Q3 Earnings: Is a Beat in Store?
Zoetis (ZTS) is anticipated to report positive earnings and revenues for third-quarter 2022. It will also provide an update on its pipeline on the earnings call.